このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

ロボット支援技術と従来の人工膝関節技術の比較 (ROCKETS)

2026年9月16日 更新者:Olof Skoldenberg、Danderyd Hospital

ROCKETS: 無作為化、多施設共同、選好寛容研究におけるロボット支援技術と従来の膝関節補綴技術の比較

Rationale for conducting the study:

The ROCKET study evaluates the clinical and economic outcomes of robot-assisted total knee arthroplasty (RTKR) compared with conventional total knee arthroplasty (TKR). The primary endpoint is the proportion of randomized participants achieving a Forgotten Joint Score (FJS) of ≥80 points at 24 months after surgery. Secondary outcomes include patient-reported knee function, health-related quality of life, self-reported instability, physical activity, radiographic alignment, surgical and technical outcomes, complications, reoperations, revisions, and health-economic outcomes.

Study design:

International multicentre, preference-tolerant, randomized, controlled superiority trial with two treatment arms comparing RTKR with conventional TKR. Participants in the randomized part are allocated 1:1. At selected centres where feasible, an optional participant-blinded randomized component may be implemented. Eligible patients who do not undergo randomization may participate in a parallel observational/preference cohort, which is analysed separately from the primary randomized comparison.

Study population:

Adults aged 18 years and older who are eligible for total knee arthroplasty according to local guidelines and who provide informed consent.

Number of patients:

Up to 1,600 randomized participants. Eligible non-randomized participants may additionally be included in the observational/preference cohort.

Primary outcome:

Proportion of randomized participants achieving FJS ≥80 points at 24 months after surgery.

Long-term follow-up:

Patient-reported and registry-based outcomes are planned at 5 and 10 years after surgery where feasible.

調査の概要

詳細な説明

The ROCKET study is an international multicentre, prospective, preference-tolerant randomized controlled superiority trial comparing robot-assisted total knee arthroplasty with conventional total knee arthroplasty.

Participants in the randomized component are allocated 1:1 to robot-assisted or conventional total knee arthroplasty. Randomization is stratified by participating centre and sex. At selected centres where practical and approved, participants may remain blinded to treatment allocation until completion of the 24-month follow-up unless earlier unblinding is clinically required or requested by the participant. Surgeons and operating-room personnel cannot be blinded. Outcome assessment is performed blinded to treatment allocation whenever feasible.

Eligible patients who are unwilling to undergo randomization, or for whom treatment equipoise cannot be achieved, may enter a parallel observational/preference cohort. Treatment in this cohort follows patient and surgeon preference. The observational/preference cohort is analysed separately from the primary randomized comparison.

The primary endpoint is the proportion of randomized participants achieving a Forgotten Joint Score (FJS) of ≥80 points at 24 months after surgery. Follow-up includes patient-reported outcomes, activity, radiographic alignment, surgical and technical variables, complications, reoperations, revisions and health-economic outcomes. Long-term follow-up is planned at 5 and 10 years after surgery, including PROMs where available and registry-based outcomes such as reoperations, revisions, complications and mortality.

研究の種類

介入

入学 (推定)

1600

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究場所

      • Hässleholm、スウェーデン、281 38
        • 募集
        • Hässleholm Hospital
      • Stockholm、スウェーデン、182 88
        • 募集
        • Danderyd Hospital
        • コンタクト:
        • 主任研究者:
          • Olof Skoldenberg, MD, PhD

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年歳以上 (大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion Criteria:

  • Adults aged 18 years and older.
  • Eligible for total knee arthroplasty according to local guidelines and routines.
  • Willingness to participate in the study.

Exclusion Criteria:

  • Patients with extreme malalignment necessitating special implants or techniques.
  • Patients unfit for surgery due to other medical reasons.
  • Patients who, for other reasons such as alcohol or substance abuse, are deemed unsuitable to participate in the study.
  • Patients who, for other reasons, cannot fulfil the required patient-reported outcome measures.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:独身

武器と介入

参加者グループ / アーム
介入・治療
実験的:RTKR

Robot-assisted total knee arthroplasty (RTKR).

Robot-assisted total knee arthroplasty using an approved robotic surgical system to assist intraoperative planning, bone preparation, implant positioning and balancing according to the participating centre's approved technique.

アクティブコンパレータ:TKR

Conventional total knee arthroplasty (TKR).

Conventional total knee arthroplasty using standard manual instrumentation according to local clinical routine.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Proportion of participants achieving a Forgotten Joint Score (FJS) ≥80 points
時間枠:24 months after surgery

The primary endpoint is the proportion of randomized participants achieving an FJS of ≥80 points at 24 months after surgery. The FJS ranges from 0 to 100, with higher scores indicating less awareness of the replaced knee during everyday activities.

24 months after surgery

二次結果の測定

結果測定
メジャーの説明
時間枠
Forgotten Joint Score (FJS), continuous score
時間枠:Baseline, 6 weeks, 12 months, 24 months, 5 years and 10 years after surgery

FJS is scored from 0 to 100, with higher scores indicating less awareness of the replaced knee.

Baseline, 6 weeks, 12 months, 24 months, 5 years and 10 years after surgery
Knee injury and Osteoarthritis Outcome Score (KOOS)
時間枠:Baseline, 6 weeks, 12 months, 24 months, 5 years and 10 years after surgery

KOOS assesses knee-related pain, symptoms, activities of daily living, sport/recreation and knee-related quality of life. Each subscale ranges from 0 to 100, with higher scores indicating better outcome.

Baseline, 6 weeks, 12 months, 24 months, 5 years and 10 years after surgery
Self-reported knee instability (ADLS items)
時間枠:Baseline, 6 weeks, 12 months, 24 months, 5 years and 10 years after surgery

Self-reported slipping/partial giving way and buckling/full giving way are assessed using items from the Activities of Daily Living Scale of the Knee Outcome Survey.

Baseline, 6 weeks, 12 months, 24 months, 5 years and 10 years after surgery
EQ-5D and EQ VAS
時間枠:Baseline, 6 weeks, 12 months, 24 months, 5 years and 10 years after surgery

Health-related quality of life is assessed using EQ-5D and EQ VAS.

Baseline, 6 weeks, 12 months, 24 months, 5 years and 10 years after surgery
Patient activity and walking distance
時間枠:Baseline, 6 weeks, 12 months, 24 months, 5 years and 10 years after surgery

Patient activity and walking distance are assessed during follow-up using the study's prespecified activity measurements.

Baseline, 6 weeks, 12 months, 24 months, 5 years and 10 years after surgery
Knee alignment
時間枠:Preoperative and approximately 6 weeks after surgery

Coronal knee alignment is assessed using long-standing radiographs, including Hip-Knee-Ankle alignment and Coronal Plane Alignment of the Knee (CPAK) classification.

Preoperative and approximately 6 weeks after surgery
Surgery time
時間枠:During the index operation

Duration of the surgical procedure is recorded in minutes.

During the index operation
Technical and intraoperative surgical outcomes
時間枠:During the index operation

Technical difficulties and prespecified intraoperative surgical details are recorded.

During the index operation
Range of motion (ROM)
時間枠:24 months after surgery

Knee range of motion is assessed at the 24-month follow-up.

24 months after surgery
Reoperations and revisions
時間枠:Up to 24 months, with additional follow-up at 5 and 10 years

Reoperations and revisions of the index knee are recorded during the primary study period and assessed during long-term follow-up where data are available.

Up to 24 months, with additional follow-up at 5 and 10 years
Adverse events and complications
時間枠:Up to 24 months, with additional long-term assessment at 5 and 10 years

Adverse events and complications related to the index knee arthroplasty are recorded. Long-term complications may additionally be assessed using approved registry or other data sources.

Up to 24 months, with additional long-term assessment at 5 and 10 years
Mortality
時間枠:90 days, 1 year, 5 years and 10 years after surgery

Mortality is assessed using available approved registry or other data sources.

90 days, 1 year, 5 years and 10 years after surgery
Health-economic outcomes
時間枠:Up to 24 months; exploratory long-term analyses at 5 and 10 years where data are available

Health-economic analyses include direct and indirect costs and cost-effectiveness using health-related quality-of-life data.

Up to 24 months; exploratory long-term analyses at 5 and 10 years where data are available

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2024年3月4日

一次修了 (推定)

2029年12月1日

研究の完了 (推定)

2037年12月1日

試験登録日

最初に提出

2024年4月4日

QC基準を満たした最初の提出物

2024年4月26日

最初の投稿 (実際)

2024年4月29日

学習記録の更新

投稿された最後の更新 (実際)

2026年9月21日

QC基準を満たした最後の更新が送信されました

2026年9月16日

最終確認日

2026年9月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • 2024DS
  • Knee (その他の識別子:Danderyds sjukhus)

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

米国で製造され、米国から輸出された製品。

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する